Preparation and Diagnosis of a Nano-Pharmaceutical Compound Derived From Graphene Oxide

In this research, a pharmaceutical nanocomposite derived from graphene oxide was prepared and characterized using the halbridiol drug. The first step involved synthesizing graphene oxide using the modified Hummers method. Next, the composite was created by reacting the graphene oxide with the halbridiol drug in deionized water as the solvent, utilizing sublimation. The validity of the prepared compound was confirmed through characterization using various spectroscopic methods, including FT-IR, FESEM, and XRD.